| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DUOL | Class A Common Stock | Options Exercise | $163K | +10K | +75.55% | $16.27* | 23.2K | Mar 3, 2023 | Direct | |
| transaction | DUOL | Class A Common Stock | Sale | -$44.9K | -400 | -1.72% | $112.35 | 22.8K | Mar 3, 2023 | Direct | F1, F2 |
| transaction | DUOL | Class A Common Stock | Sale | -$22.6K | -200 | -0.88% | $113.20 | 22.6K | Mar 3, 2023 | Direct | F1 |
| transaction | DUOL | Class A Common Stock | Sale | -$175K | -1.5K | -6.63% | $116.78 | 21.1K | Mar 3, 2023 | Direct | F1, F3 |
| transaction | DUOL | Class A Common Stock | Sale | -$1.01M | -8.58K | -40.61% | $117.98 | 12.6K | Mar 3, 2023 | Direct | F1, F4 |
| transaction | DUOL | Class A Common Stock | Sale | -$746K | -6.28K | -49.98% | $118.93 | 6.28K | Mar 3, 2023 | Direct | F1, F5 |
| transaction | DUOL | Class A Common Stock | Sale | -$364K | -3.04K | -48.45% | $119.70 | 3.24K | Mar 3, 2023 | Direct | F1, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DUOL | Stock Option (Right to Buy) | Options Exercise | $0 | -10K | -33.33% | $0.00 | 20K | Mar 3, 2023 | Class A Common Stock | 10K | $16.27 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. |
| F2 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $112.20 to $112.49, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $116.34 to $117.17, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $117.35 to $118.33, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $118.35 to $119.33, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $119.35 to $120.14, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F7 | 25% of the shares subject to the option vest annually measured from June 10, 2020 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |